Skip to content
10-K

Annual Report

MUSTANG BIO, INC. MBIO

0001104659-26-032063

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 4.91M sh
Shares Diluted FY 2025 · Dec 31, 2024 609.7K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$5.26M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$11.41M
Cash And Equivalents FY 2025 · Dec 31, 2025 $17.27M
Cash And Equivalents FY 2025 · Dec 31, 2024 $6.84M
Stockholders Equity FY 2025 · Dec 31, 2025 $9.53M
Stockholders Equity FY 2025 · Dec 31, 2024 −$3.87M
Stockholders Equity FY 2025 · Dec 31, 2023 $123K
Current Liabilities FY 2025 · Dec 31, 2025 $7.91M
Current Liabilities FY 2025 · Dec 31, 2024 $12.61M
Total Liabilities FY 2025 · Dec 31, 2025 $8.06M
Total Liabilities FY 2025 · Dec 31, 2024 $13.18M
Current Assets FY 2025 · Dec 31, 2025 $17.59M
Current Assets FY 2025 · Dec 31, 2024 $8.61M
Total Assets FY 2025 · Dec 31, 2025 $17.59M
Total Assets FY 2025 · Dec 31, 2024 $9.31M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.39
Eps Diluted FY 2025 · Dec 31, 2024 −$38.57
Eps Basic FY 2025 · Dec 31, 2025 −$0.39
Eps Basic FY 2025 · Dec 31, 2024 −$38.57
Sga Expense FY 2025 · Dec 31, 2025 $3.95M
Sga Expense FY 2025 · Dec 31, 2024 $4.14M
Net Income FY 2025 · Dec 31, 2025 −$1.92M
Net Income FY 2025 · Dec 31, 2024 −$15.75M
Operating Income FY 2025 · Dec 31, 2025 −$2.43M
Operating Income FY 2025 · Dec 31, 2024 −$16.25M